Taken together, these results suggest that enhanced NMDAR signaling underlies the autistic-like features, but not learning and memory deficits, in CDKL5-deficient mice, and reveal the translational potential of this pathway in the treatment of CDD. The gene discussed is CDKL5; the disease is craniodiaphyseal dysplasia.